| Detection of tumor circulating cells by cytokeratin-20 in the blood of patients with granulosa cell tumors. | |
| | |
MedLine Citation:
|
PMID: 12217756 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Cytokeratins (CKs) are constituents of the intermediate filaments of epithelial cells which are expressed in various combinations, depending on the epithelial type and the degree of differentiation. Using the reverse transcriptase-polymerase chain reaction (RT-PCR) technique, we recently demonstrated that cytokeratin-20 (CK-20), the most recently discovered cytokeratin, is expressed in endometrial carcinoma tumors, in blood, and in lymph nodes with micrometastases of patients treated for endometrial carcinomas. However, CK-20 expression could not be demonstrated in the endometrium of patients with benign diseases, in peripheral blood, in lymph nodes of healthy subjects, or in normal blood cells. The aim of this study was to examine whether CK-20 expression in blood can be used as a biomarker for the detection of the dissemination of malignant cells in patients treated for granulosa cell tumors (GCTs). METHODS: In this study, we used RT-PCR to determine the expression of CK-20 in the following groups: (i) blood of patients (n = 14) treated for GCTs, (ii) GCT samples (n = 4); (iii) lymph nodes (n = 2) of patients treated for GCTs; (iv) blood from subjects with benign sex-cord-stromal tumors (n = 2); (v) normal ovaries of two menstruating women (n = 4); (vi) tumor specimens of epithelial ovarian carcinomas (EOCs) (n = 14); and (vii) blood samples (n = 18) and lymph nodes (n = 11) of healthy women. RESULTS: In Group I, CK-20 was positive in the blood in 86% (12/14) of the patients. In Group II, CK-20 was positive in 100% (4/4) of the GCT samples. In Group III, CK-20 was positive in 100% (2/2) of the lymph nodes examined. In Groups IV and V, CK-20 was negative in 100% (2/2) of the blood samples and in the normal ovarian specimens (4/4) that were examined. In Group VI, CK-20 was positive in 14% (2/14) of nonmucinous EOCs. In Group VII, CK-20 was negative in 100% (18/18) of blood and in (11/11) lymph node specimens (specificity 100%). CONCLUSIONS: These results indicate that RT-PCR of CK-20, because of its high sensitivity and specificity, is a potential biomarker for detecting metastases in blood and in micrometastases in lymph nodes of patients treated for GCTs. |
| | |
Authors:
|
Marco M Altaras; Ami Klein; Ruth Zemer; Shulamit Zimlichman; Joelle Bernheim; Ami Fishman |
Related Documents
:
|
11281176 - Which is a less invasive pancreatic head resection: pd, pppd, or dpphr? 22584016 - Theoretical study of the flow rate toward the right heart territory in case of total oc... 8545246 - Pancreatic polypeptide and splanchnic blood flow in anesthetized rats. 7117326 - Correlation of pancreatic blood flow and high-energy phosphates during experimental pan... 15153246 - Blunt trauma to large vessels: a mathematical study. 8925346 - Effects of the clozapine national registry system on incidence of deaths related to agr... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Gynecologic oncology Volume: 86 ISSN: 0090-8258 ISO Abbreviation: Gynecol. Oncol. Publication Date: 2002 Sep |
Date Detail:
|
Created Date: 2002-09-09 Completed Date: 2002-10-03 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 0365304 Medline TA: Gynecol Oncol Country: United States |
Other Details:
|
Languages: eng Pagination: 330-6 Citation Subset: IM |
Affiliation:
|
Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Sapir Medical Center, Kfar Saba 44281, Israel. altaras@clalit.org.il |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Aged, 80 and over Female Granulosa Cell Tumor / blood*, pathology Humans Intermediate Filament Proteins / biosynthesis, blood* Keratin-20 Lymph Nodes / metabolism, pathology Lymphatic Metastasis Middle Aged Neoplastic Cells, Circulating / metabolism*, pathology Ovarian Neoplasms / blood*, pathology Reverse Transcriptase Polymerase Chain Reaction |
| Chemical | |
Reg. No./Substance:
|
0/Intermediate Filament Proteins; 0/KRT20 protein, human; 0/Keratin-20 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Saline infusion sonography and office hysteroscopy to assess endometrial morbidity associated with t...
Next Document: Shortcomings and deficits in surgical treatment of gynecological cancers: a German problem only?